[Congressional Record Volume 149, Number 25 (Tuesday, February 11, 2003)]
[Senate]
[Page S2183]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
DUCHENNE MD AWARENESS WEEK
Ms. COLLINS. Mr. President, this week is the Parent Project Muscular
Dystrophy's Duchenne MD Awareness Week. It is also the 2-year
anniversary of the introduction of the MD CARE Act, which I was pleased
to cosponsor with our late colleague, Senator Paul Wellstone, to raise
awareness and expand Federal support for medical research to find a
cure for this devastating disease.
The need for this legislation was first brought to my attention by
one of my constituents, Brian Denger, of Biddeford, ME, who has not
one, but two wonderful boys--Matthew and Patrick--with Duchenne
Muscular Dystrophy. The Dengers--who also have a daughter, Rachel, with
juvenile diabetes--are a loving and courageous family whose strength
and spirit inspired me to become involved in advocating for more
research funding for muscular dystrophy.
Until I met Brian, I really did not know much about Duchenne Muscular
Dystrophy. He was the first to tell me that 1 in 3,500 male children
worldwide will be born with the disease and lose the ability to walk by
age 10. He told me about the terrible progression of the disease. As it
progresses, muscle deterioration in the back and chest begins to put
pressure on the lungs, making it more and more difficult for the child
to breathe.
What really caught my attention was the fact that the lifespan of
children suffering from this disease has not been extended in any
significant way in recent years. Current treatment options for boys
like Matthew and Patrick are minimal and aimed simply at managing their
symptoms in an effort to optimize their quality of life for the limited
time they have with us.
Given our Nation's wealth of scientific expertise coupled with the
tremendous infusion of resources we have poured into the NIH in recent
years, we can and should do more for families like the Dengers. That is
why I joined with Senator Wellstone in introducing the MD CARE Act,
which President Bush signed into law in December of 2001.
Since the passage of this important legislation, the National
Institutes of Health have established grants for the creation of three
Centers of Excellence in Muscular Dystrophy Research, which will
provide focused research and development in all phases--including
basic, clinical, and transitional--of the research spectrum. In
addition, the Centers for Disease Control and Prevention have developed
an in-depth surveillance and epidemiology study of Duchenne and Becker
muscular dystrophy. A population-based epidemiological study of
Duchenne and Becker muscular dystrophy will provide the extensive data
necessary to inform research decisions, standards of care, physician
training, and public health approaches to assist families living with
Duchenne and Becker muscular dystrophy.
The NIH and the CDC are to be commended for the progress they are
making in their research efforts related to muscular dystrophy. These
efforts to improve the quality and length of life for thousands of
children diagnosed with muscular dystrophy are invaluable, and I
commend the researchers and all of the families who have worked so hard
to combat this devastating disease.
____________________